arrow
F

Francesca Del Bufalo

bambino gesu childrens hospital
H指数:33
被引数:3,138

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dinutuximab beta with TEMIRI chemotherapy in relapsed/refractory neuroblastoma: Real-world insights into the open question of GD2 expression

替伊鲁单抗β联合TEMIRI化疗在复发/难治性神经母细胞瘤中的应用:关于GD2表达这一开放性问题的真实世界见解

2026-09-010
OAAI
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases

Anti-CD19 CAR T细胞治疗难治性自身免疫性疾病的儿科患者

2026-02-050
PRE
Preoperative Cytopenia in Patients Affected by High-Risk Neuroblastoma: Just a Matter of Platelets?

高危神经母细胞瘤患者的术前血细胞减少症:仅仅是血小板的问题吗?

2025-12-010
OAAI
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial

GD2靶向CAR T细胞在高风险神经母细胞瘤中的应用:一项I/II期临床试验。Nat. Med

2025-08-210
PRE
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse

用于儿科或年轻成人复发性/难治性或极高危首次复发的BCP-ALL的床旁新鲜CAR T细胞

2025-06-260
OAAI
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee

CAR T细胞疗法后较少见的并发症:噬血细胞性淋巴组织细胞增多症、移植物抗宿主病、血栓性微血管病、凝血障碍和继发性恶性肿瘤:EBMT实践协调与指南委员会的最佳实践建议

2025-04-090
PRE
131I-mIBG therapy in relapsed/refractory neuroblastoma: an old bridge to the future

¹³¹I-mIBG疗法在复发/难治性神经母细胞瘤中的应用:一座通往未来的古老桥梁

2025-04-010
OAAI
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells

肿瘤衍生的g-csf在骨肉瘤模型中诱导免疫抑制微环境,降低对CAR.GD2 T细胞的反应

2024-12-180
OAAI
Rescuing of the Chemotherapy Sensitivity in Relapsed/Refractory, Pediatric Acute Lymphoblastic Leukemia (r/r ALL) through the Combination of Navitoclax (NAV) and Venetoclax (VEN): Results of Compassionate Use across Four European Countries

通过Navitoclax(NAV)和Venetoclax(VEN)联合应用挽救复发/难治性、儿童急性淋巴细胞白血病(r/r ALL)的化疗敏感性:来自四个欧洲国家同情用药的结果

BLOOD
IF23.1
2024-11-050
PRE
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation

blinatumomab作为异基因造血干细胞移植前最后巩固治疗的儿童和青年b细胞急性淋巴细胞白血病的结果

2024-10-312
OAAI
Fratricide-resistant CD7-CAR T cells in T-ALL

T-all中的抗自杀性CD7-CAR T细胞

2024-09-033
PRE
Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis

难治性青少年皮肌炎患者的自体CD19-Targeting CAR T细胞

2024-07-315
PRE
Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells
2024-06-300
OAAI